Table 1. Clinical characteristics of TCGA GC patients.
| Variables | TCGA cohort (n=443) |
|---|---|
| Status | |
| Alive | 272 (61.4) |
| Dead | 171 (38.6) |
| Age | 66 ± 10.76 |
| Gender | |
| Female | 158 (35.6) |
| Male | 285 (64.4) |
| AJCC‐T | |
| T1 | 23 (5.2) |
| T2 | 93 (21.0) |
| T3 | 198 (44.7) |
| T4 | 119 (26.9) |
| TX | 10 (2.2) |
| AJCC‐N | |
| N0 | 132 (29.8) |
| N1 | 119 (26.9) |
| N2 | 85 (19.2) |
| N3 | 88 (19.9) |
| NX | 17 (3.8) |
| Unknown | 2 (0.4) |
| AJCC‐M | |
| M0 | 391 (88.3) |
| M1 | 30 (6.8) |
| MX | 22 (4.9) |
| Pathologic stage | |
| I–II | 192 (43.3) |
| III–IV | 224 (50.6) |
| Unknown | 27 (6.1) |
| Tumor grade | |
| G1–G2 | 171 (38.6) |
| G3 | 263 (59.4) |
| GX | 9 (2.0) |